Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Pernot

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patientsJeanne Lena, Mélissa Alamé, Antoine Italiano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 9, 2019
Factors associated with anal cancer screening uptake in men who have sex with men living with HIV: a cross-sectional studyAlexis Vanhaesebrouck, Simon Pernot, Juliette Pavie, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2010
Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenibViolaine Ozenne, Valerie Paradis, Simon Pernot, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 29, 2026
Furin-like enzyme dependency in KRAS-mutant colorectal cancer as a target for personalized treatment strategiesGeraldine Siegfried, Yiyang Liu, Zongcheng He, et al.
Clinics and Research in Hepatology and Gastroenterology|July 5, 2015
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trialSimon Pernot, Pascal Artru, François Mithieux, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategyAlix Portal, Simon Pernot, Nathalie Siauve, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2019
HPV-circulating tumoural DNA by droplet-based digital polymerase chain reaction, a new molecular tool for early detection of HPV metastatic anal cancer? A case reportDavid Veyer, Juliette Pavie, Simon Pernot, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
European Radiology|April 3, 2019
Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?Olivier Pellerin, Helena Pereira, Claire Van Ngoc Ty, et al.
Therapeutic Advances in Gastroenterology|January 22, 2024
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should <i>KRAS</i> mutation research be recommended in everyday practice?Dominique Béchade, Lola-Jade Palmieri, Benjamin Bonhomme, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patientsJeanne Lena, Mélissa Alamé, Antoine Italiano, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 9, 2019
Factors associated with anal cancer screening uptake in men who have sex with men living with HIV: a cross-sectional studyAlexis Vanhaesebrouck, Simon Pernot, Juliette Pavie, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2010
Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenibViolaine Ozenne, Valerie Paradis, Simon Pernot, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 29, 2026
Furin-like enzyme dependency in KRAS-mutant colorectal cancer as a target for personalized treatment strategiesGeraldine Siegfried, Yiyang Liu, Zongcheng He, et al.
Clinics and Research in Hepatology and Gastroenterology|July 5, 2015
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trialSimon Pernot, Pascal Artru, François Mithieux, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategyAlix Portal, Simon Pernot, Nathalie Siauve, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2019
HPV-circulating tumoural DNA by droplet-based digital polymerase chain reaction, a new molecular tool for early detection of HPV metastatic anal cancer? A case reportDavid Veyer, Juliette Pavie, Simon Pernot, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
European Radiology|April 3, 2019
Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?Olivier Pellerin, Helena Pereira, Claire Van Ngoc Ty, et al.
Therapeutic Advances in Gastroenterology|January 22, 2024
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should <i>KRAS</i> mutation research be recommended in everyday practice?Dominique Béchade, Lola-Jade Palmieri, Benjamin Bonhomme, et al.
Pageof 11